While tech players like Apple and Microsoft danced around the medtech market this year, Google, the sector’s 800-pound gorilla, entered it in earnest.
The Web search giant grabbed industry headlines in January with the announcement that its secretive Google[x] lab was working on smart contact lenses that can monitor blood glucose levels. By July it had inked a deal with Novartis’s Alcon eye division to develop and commercialize the technology.
And the company isn’t stopping there. In October, Andrew Conrad, who leads the life sciences team at Google[x], revealed an ambitious project that aims to create controllable nanoparticles that can be deployed inside the body to diagnose diseases.
Google's pie-in-the-sky aspirations and sci-fi-like advances also earned it the title of MD+DI's 2014 Medtech Company of the Year.